Comparison of Full-Field Digital Mammography With Digital Breast Tomosynthesis Image Acquisition in Relation to Screening Call-Back Rate
Asymptomatic women 25 years and older with no history of breast cancer will be recruited
from a prospective population of patients scheduled for screening mammography (Group A). A
similar population of women called back from screening for 2-D FFDM-detected abnormalities
will also be recruited to provide an enriched population of true-positive and false-positive
2-D FFDM and tomosynthesis cases (Group B). Pregnant women, women unable to tolerate
compression of the breast associated with mammography, women with implants, and women with
breasts too large to accommodate adequate positioning of the breast for DBT are excluded
from trial participation.
A total of 550 participants will be recruited--500 women will enroll for collection of
prospective imaging data in this trial (Group A); 50 additional participants, recalled for
diagnostic assessment after positive screening findings, will be recruited for DBT imaging
data collection and retrospective image analysis (Group B). Participating institutions for
this trial will be clinical research institutions in Pennsylvania with Hologic tomosynthesis
units.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening
Primary Aim: Recall Rates
To compare recall rates of FFDM to the limited DBT set (digital breast two-view tomosynthesis with low-dose MLO) [Group A].
1 year
No
Emily F. Conant, MD
Study Chair
Hospital of University of Pennsylvania
United States: Institutional Review Board
ACRIN PA 4006
NCT01236781
December 2010
Name | Location |
---|---|
Hospital of University of Pennsylvania | Philadelphia, Pennsylvania 19104 |
Albery Einstein Medical Center | Philadelphia, Pennsylvania 19141 |